HMGB1

HMGB1

HMGB1 Informations sur la molécule

Molecule Name
High Mobility Group Protein B1
Alias de la molécule
HMGB1,HMG1,HMG3,SBP-1
Drug Development Progress
Nombre de médicaments cliniques1
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
FM1 Gene Product,HMG 1 Protein,HMG-1 Protein,HMG1,Heparin-Binding Protein p30,High Mobility Group Box 1,High-Mobility Group (Nonhistone Chromosomal) Protein 1,High Mobility Group Protein B1,High Mobility Group Protein 1,HMG-1,Sulfoglucuronyl Carbohydrate Binding Protein,Amphoterin,Box Protein 1, High Mobility Group,SBP-1,High-Mobility Group Box 1,DKFZp686A04236,HMGB1
Contexte de la molécule
High-mobility group protein B1 (HMGB1) is also known as high-mobility group protein 1 (HMG-1) and amphoterin, is a member of the HMGB family consisting of three members, HMGB1, HMGB2 and HMGB3. HMGB1 is a non-histone architectural chromosomal protein ubiquitously present in all vertebrate nuclei and binds double-stranded DNA without sequence specificity. The mechanism of inflammation and damage is binding to TLR4, which mediates HMGB1-dependent activation of macrophage cytokine release. This positions HMGB1 at the intersection of sterile and infectious inflammatory responses. HMGB1 has been studied as a DNA vaccine adjuvant and a target for cancer therapy.

HMGB1 Liste de produits

Species
  • Human(3)
  • Mouse(1)
Tag
  • His Tag(2)
  • His Tag & Avi Tag(1)
  • Mouse IgG Fc Tag(1)
Host
  • HEK293(4)
Conjugate
  • Unconjugated(3)
  • Biotin-labeled(1)
Grade
  • RUO(4)
Low Endotoxin
  • Yes(1)
  • No(3)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
HMGB1
Human HMGB1 Protein, His Tag, low endotoxin
Human
HEK293
SDS-PAGE
ELISA

$400.00

100ug
HMGB1
Human HMGB1 Protein, Mouse IgG2a Fc Tag
Human
HEK293
SDS-PAGE
CELL BASE

$380.00

100ug
HMGB1
Avitag
HM1-H82E3
Biotinylated Human HMGB1 Protein, His,Avitag™
Human
HEK293
SDS-PAGE

$360.00

25ug
HMGB1
Mouse HMGB1 Protein, His Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$410.00

100ug
You Have Viewed 1-4 Of 4 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
SB-17170SB-17170Phase 2 ClinicalSpark Biopharma Inc
Drug-Related Side Effects and Adverse Reactions; Idiopathic Pulmonary Fibrosis; Solid tumours
Details
Customer Reviews